When injected, it stimulates pulsatile growth hormone release that mimics your bodys natural rhythm rather than providing constant artificial elevation
This improvement is associated with reduced leukocyte-endothelial interactions and inflammation, potentially lowering the risk of atherosclerosis and cardiovascular diseases
However, the migraine attack duration decreased only in the chronic migraine patients
In 2023, the FDA launched an investigation after GLP-1 agonist users started reporting thoughts of suicide as of January 2024, it hadnt found anything to confirm the connection, but it also said it couldnt yet rule it out, meaning its possible the drugs could cause mental health issues for some people, rather than treating or preventing them
Status updates tied to intake review or pharmacy coordination once approval has occurred
DISPOSE OF THE SYRINGE AND NEEDLE SAFELY USING THE SAFE-CLIP